Effect of PCO2 Gap Algorithm Application on Outcome of High Risk Surgical Patients Undergoing Major Abdominal Surgeries

Sponsor
South Valley University (Other)
Overall Status
Completed
CT.gov ID
NCT04792242
Collaborator
(none)
40
1
2
15.9
2.5

Study Details

Study Description

Brief Summary

  1. Primary (main):

Comparison between goal directed therapy and PCO2 gap algorithm (carbon dioxide partial pressure venous arterial gap algorithm) application on 30 days mortality and organ dysfunction post operative

  1. Secondary (subsidiary):

Comparison between goal directed therapy and PCO2 gap algorithm application on number of ventilator dependant days, number of days on vasopressors or inotropes length of ICU stay, length of hospital stay,

Condition or Disease Intervention/Treatment Phase
  • Device: cv line insertion
  • Device: Urinary catheter insertion
  • Device: Arterial line
N/A

Detailed Description

High risk surgical participants in South valley university hospitals (teaching hospitals) who will undergo major abdominal surgeries will be included in research after giving written informed consent from the participants or from the patient's legal representative. The use of obtained data will be approved by local ethics committee.

All participants will be evaluated pre operatively and pre medicated according to protocols in our hospital, base line sequential organ failure (SOFA) score will be taken. General anesthesia for all patients will be carried on according to our local standards. As part of our routine hemodynamic monitoring during major surgery, all patients will be monitored with central venous (standard three-lumen catheter) and arterial catheters placed before the beginning of surgery. The central venous line will be positioned with the tip within the superior vena cava, and correct positioning will be verified by chest radiograph.

the participants will be divided randomly onto to groups using numerical system group A PCO2 gap algorithm(carbon dioxide partial pressure venous arterial gap) will be applied intraoperative and 12 h postoperative end point PCO2 gap 2-6mm Hg(appendix 1).

Group B goal directed therapy protocol which will include targets mean arterial blood pressure ( MAP) > 65 mmHg, central venous pressure(CVP) between 8-12 cmH2O , Haematocrite value more than 30, mixed venous oxygen saturation (Svo2) >75% and urine output more than

0.5 ml/kg/hr and will be applied intraoperative and 12 postoperative end point base deficit +/- 2(appendix 2 ).

All participants will be admitted to the ICU (intensive care unit) immediately after surgery .Standard postoperative monitoring will include: electrocardiograph (heart rate), invasive mean arterial pressure, pulse oxygen saturation and urine output then will be all managed according to their allocated group for 12 hours.

Outcomes in both groups will be recorded which will be number of ventilator dependant days, number of days on vasopressors or inotropes length of ICU stay, length of hospital stay, 30 days organ dysfunction, assessed by using the Sequential Organ Failure Assessment (SOFA) and 30 days mortality .

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
case controlcase control
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Comparison Between Goal Directed Therapy and PCO2 Gap Algorithm Application on Outcome of High Risk Surgical Patients Undergoing Major Abdominal Surgeries
Actual Study Start Date :
Nov 10, 2019
Actual Primary Completion Date :
Dec 21, 2020
Actual Study Completion Date :
Mar 7, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: goal directed therapy

svo2,haematocrite value,urine output,mean arterial pressure and central venous pressure

Device: cv line insertion
Svo2 and central venous pressure measurements

Device: Urinary catheter insertion
urine output measurement

Active Comparator: PCO2 gap algorithm

PCO2 gap,haematocrite value,Spo2,cardiac index

Device: cv line insertion
Svo2 and central venous pressure measurements

Device: Urinary catheter insertion
urine output measurement

Device: Arterial line
Arterial blood gases measurment

Outcome Measures

Primary Outcome Measures

  1. Post operative mortality [30 days]

    early post operative mortality

Secondary Outcome Measures

  1. post operative organ failure [30 days]

    cardiac,renal,respiratory,renal central nervous system(CNS) failure by sequential organ failure(SOFA) score

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical criteria for high-risk surgical patients used by Shoemaker and colleagues and adapted by Boyd and colleagues
Exclusion Criteria:
  • patients who will refuse to continue on research patients who will not be admitted post operative in the ICU

Contacts and Locations

Locations

Site City State Country Postal Code
1 South Valley University Luxor Qena Egypt 83523

Sponsors and Collaborators

  • South Valley University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hassan Abdelsapour Abdelrazek, PhD Candidat, South Valley University
ClinicalTrials.gov Identifier:
NCT04792242
Other Study ID Numbers:
  • SVU.MED.AIP029.4.1
First Posted:
Mar 10, 2021
Last Update Posted:
Mar 23, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 23, 2021